Lupin Pharmaceuticals Inc. recalls Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals,
Lupin Pharmaceuticals recalls 30mg Duloxetine capsules due to failed dissolution specification. This may affect drug effectiveness. Check NDC 68180-295-06 or lot number G602051 for affected products.
Lower-risk recall
Failed Dissolution Specification
Contact the company & request your remedy
What happened, in plain English
Lupin Pharmaceuticals is recalling 30mg Duloxetine Delayed-Release Capsules because they may not dissolve properly. This could lead to incorrect drug dosing and reduced effectiveness. Affected products have specific lot numbers and NDC codes. Read more at govinfonow.com/recall/41043-lupin-duloxetine-capsules-recall-failed-dissolution-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/41043-lupin-duloxetine-capsules-recall-failed-dissolution-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0097-2018
Cite this page
“Lupin Duloxetine Capsules Recall: Failed Dissolution Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41043-lupin-duloxetine-capsules-recall-failed-dissolution-risk. Based on FDA recall #D-0097-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0097-2018%22&limit=1).
Why it’s dangerous
The capsules may not dissolve correctly in the stomach, which could lead to incorrect drug dosing. This might reduce the medication's effectiveness for treating depression or nerve pain.
Who’s affected
Prescription users of Duloxetine 30mg capsules with NDC 68180-295-06 or lot number G602051. People taking this medication for depression or nerve pain are most at risk.
How to tell if you have this one
Check the product label for NDC 68180-295-06 or lot number G602051. The product is a 30mg Duloxetine Delayed-Release Capsules USP, 30-count bottle, prescription-only item.
- Brand
Lupin Pharmaceuticals- Product
Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 68180-295-06 or lot number G602051 on the bottle.
Questions people ask
Why is this product being recalled?
The capsules may not dissolve properly, which could lead to incorrect dosing and reduced effectiveness.
What should I do if I have this product?
Check the product label for NDC 68180-295-06 or lot number G602051. If you have the affected product, contact your doctor or pharmacist for guidance.
Is there a risk of serious injury?
The recall is for potential reduced effectiveness, not a risk of serious injury. This is a low-risk issue.
Contact Lupin Pharmaceuticals
We’ve drafted a message you can send Lupin Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0097-2018 — Lupin Pharmaceuticals Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Ma Hello, I own a Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals that is covered by recall D-0097-2018 from Lupin Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0097-2018 (November 21, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0097-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.